EP4 receptor antagonist 3

• UNSPSC Description:

  EP4 receptor antagonist 3 is a potent EP4 receptor antagonist, example 3,extracted from patent WO2010019796 A1. EP4 receptor antagonist 3 can be used for the reseacrh of EP4 receptor-mediated diseases, such as acute and chronic pain, osteoarthritis, rheumatoid arthritis and cancer[1].

• Target Antigen:

  Prostaglandin Receptor

• Type:

  Reference compound

• Related Pathways:

  GPCR/G Protein

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Cancer; Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/ep4-receptor-antagonist-3.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(O)C1=CC=C(C2(NC(C3=C(C)SC4=C3N(CC5=CC=C(C(F)(F)F)C=C5)C=C4)=O)CC2)C=C1

• Molecular Weight:

  498.52

• References & Citations:

  [1]Wei W. Yuan, et al. Heterocyclic amide derivatives as ep4 receptor antagonists. Patent WO2010019796A1.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  1207954-34-4